The Division of Molecular Therapeutics and Formulation carries out leading edge research into new drugs, emerging therapeutic targets, and the materials and processes which turn these drugs and targets into medicines. The breadth of research fields underlying Molecular Therapeutics and Formulation is very large, ranging from fundamental biology to pharmaceutical technology.
This is an exciting and rapidly moving area of science, with new discoveries and advances constantly emerging from our labs and those all around the world. Researchers in the Division work in multi-disciplinary teams, often with collaborators in other countries and with industry, in order to design, understand and develop new and often highly complex pharmaceutical agents.
Head of Division: Professor Cameron Alexander
Divisional Research Assistant: Carol Turrill
See a list of our academic and research staff and our postgraduate students
Molecular therapeutics include peptides, proteins, antibodies, nucleic acids, gene constructs, whole cells and hybrids/conjugates of these agents. Sub-groups within the Division focus on synthesis of new materials to deliver these agents to target sites.... see more
Expertise - synthetic organic and physical chemistry, cell and molecular biology, colloid and materials science, pharmacokinetics and pharmaceutics.
MRes project for self-funded student
Linking in Vitro Lipolysis and Microsomal Metabolism for the Quantitative Prediction of Oral Bioavailability of BCS II Drugs Administered in Lipidic Formulations.
The role of acid-base imbalance in statin-induced myotoxicity
University of NottinghamUniversity Park
Nottingham, NG7 2RD
For all enquiries please visit:
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs
Browser does not support script.